This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08174/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08174/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08174/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08174/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08174/identifier/chemspider/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08174
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB08174 n13:DB08174
dcterms:title
5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE
adms:identifier
n4:ME5 n7:9954980 n11:8130590 n12:DB08174 n14:99444645
n5:IUPAC-Name
n6:271B3E7B-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3E81-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3E80-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3E7D-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3E7E-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3E7F-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3E79-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3E77-363D-11E5-9242-09173F13E4C5 n6:271B3E7A-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3E78-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3E87-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3E88-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3E82-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3E83-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3E85-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3E84-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3E86-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3E8D-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3E8F-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3E90-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3E8C-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3E8B-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3E8E-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3E7C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3E89-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3E8A-363D-11E5-9242-09173F13E4C5